Concepedia

Seth Thompson

ST

24

Publications

2.3K

Citations

20

H-Index

1988

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Institute for Cancer Prevention

Columbia University

Université Paris Cité

New York University

Seth Thompson is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, viral hepatitis, and hepatitis.

Top concepts

Publications per year

1988–2023

24

Publications

24

Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer

Jean‐Yves Douillard, Paulo M. Hoff, Jamey Skillings et al. · Journal of Clinical Oncology · 2002 · 322 citations

CYTOTOXIC CHEMOTHERAPY FOR ADVANCED RENAL CELL CARCINOMA

Alan Yagoda, Daniel P. Petrylak, Seth Thompson · Urologic Clinics of North America · 1993 · 206 citations

, , +1

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

Mark Sulkowski, Stanislas Pol, Josep Mallolas et al. · The Lancet Infectious Diseases · 2013 · 180 citations

, , +9

Screening Scale Predicts Patients Successfully Receiving Long-term Implantable Left Ventricular Assist Devices

Mehmet C. Öz, Daniel J. Goldstein, Paolo Pepino et al. · Circulation · 1995 · 178 citations

Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking

Steven D. Stellman, Joshua Muscat, Seth Thompson et al. · Cancer · 1997 · 171 citations · Full text

Rows per page

1–5 of 24